0001144204-12-006433.txt : 20120207 0001144204-12-006433.hdr.sgml : 20120207 20120207171701 ACCESSION NUMBER: 0001144204-12-006433 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120207 DATE AS OF CHANGE: 20120207 EFFECTIVENESS DATE: 20120207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-173040 FILM NUMBER: 12578754 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 D 1 primary_doc.xml X0704 D LIVE 0001059784 GENEREX BIOTECHNOLOGY CORP 33 HARBOUR SQ SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 4163642551 DELAWARE None None Corporation true Mark A. Fletcher 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Executive Officer Director Nola E. Masterson 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Eric von Hofe, Ph.D. 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director James H. Anderson, Jr., M.D. 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Stephen Fellows 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Executive Officer David Brusegard, Ph.D. 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Executive Officer John P. Barratt 33 HARBOUR SQUARE SUITE 202 TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Brian T. McGee 33 HARBOUR SQUARE TORONTO A6 ONTARIO, CANADA M5J 2G2 Director Pharmaceuticals $1 - $1,000,000 06 false 2012-02-01 false true true true false 50000 Seahawk Capital Partners, Inc. None None None 147 MAIN STREET, SECOND FLOOR COLD SPRING HARBOR NY NEW YORK 11724 NJ NEW JERSEY NY NEW YORK false 2000000 2000000 0 false 7 0 160000 0 false GENEREX BIOTECHNOLOGY CORP /s/ Mark A. Fletcher Mark A. Fletcher President 2012-02-06